Vitamin B Health Claim Omits CDC Homocysteine Findings, Plaintiffs Say
This article was originally published in The Tan Sheet
Executive Summary
FDA should amend its vitamin B qualified health claim to reflect a Centers for Disease Control & Prevention statement recognizing elevated plasma homocysteine as a vascular disease risk factor, plaintiffs in the Whitaker v. Shalala case assert.